China National Medicines Corp Ltd (600511) — Cash Flow-to-Debt Ratio
China National Medicines Corp Ltd (600511) has a Cash Flow-to-Debt Ratio of -0.04x as of September 2025, meaning its operating cash flow of CN¥-540.00 Million could theoretically repay 0% of its total liabilities (CN¥15.19 Billion) in one year. See 600511 cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
China National Medicines Corp Ltd Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for China National Medicines Corp Ltd across 24 annual periods. Also explore China National Medicines Corp Ltd annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for China National Medicines Corp Ltd (2001–2024)
Year-by-year debt coverage analysis for China National Medicines Corp Ltd. For market capitalisation and broader financial context, see 600511 market cap.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.10x | CN¥1.66 Billion | CN¥15.95 Billion | ▼ -43.1% |
| 2023 | 0.18x | CN¥2.73 Billion | CN¥14.92 Billion | ▲ +4.9% |
| 2022 | 0.17x | CN¥2.40 Billion | CN¥13.75 Billion | ▲ +16.8% |
| 2021 | 0.15x | CN¥1.96 Billion | CN¥13.12 Billion | ▲ +35.4% |
| 2020 | 0.11x | CN¥1.30 Billion | CN¥11.81 Billion | ▼ -25.3% |
| 2019 | 0.15x | CN¥1.78 Billion | CN¥12.03 Billion | ▲ +63.9% |
| 2018 | 0.09x | CN¥981.65 Million | CN¥10.90 Billion | ▼ -10.2% |
| 2017 | 0.10x | CN¥1.07 Billion | CN¥10.71 Billion | ▼ -42.6% |
| 2016 | 0.17x | CN¥591.25 Million | CN¥3.38 Billion | ▲ +20.7% |
| 2015 | 0.14x | CN¥440.29 Million | CN¥3.04 Billion | ▲ +95.5% |
| 2014 | 0.07x | CN¥218.94 Million | CN¥2.96 Billion | ▲ +15.1% |
| 2013 | 0.06x | CN¥185.56 Million | CN¥2.88 Billion | ▼ -6.9% |
| 2012 | 0.07x | CN¥185.87 Million | CN¥2.69 Billion | ▲ +137.6% |
| 2011 | -0.18x | CN¥-370.56 Million | CN¥2.02 Billion | ▼ -218.2% |
| 2010 | 0.16x | CN¥318.21 Million | CN¥2.05 Billion | ▲ +3.0% |
| 2009 | 0.15x | CN¥255.18 Million | CN¥1.69 Billion | ▼ -21.7% |
| 2008 | 0.19x | CN¥217.10 Million | CN¥1.13 Billion | ▲ +197.7% |
| 2007 | 0.06x | CN¥79.48 Million | CN¥1.23 Billion | ▼ -59.0% |
| 2006 | 0.16x | CN¥121.50 Million | CN¥771.05 Million | ▲ +29.8% |
| 2005 | 0.12x | CN¥92.20 Million | CN¥759.27 Million | ▲ +74.0% |
| 2004 | 0.07x | CN¥49.18 Million | CN¥704.48 Million | ▲ +8123.0% |
| 2003 | 0.00x | CN¥526.15K | CN¥619.80 Million | ▼ -97.7% |
| 2002 | 0.04x | CN¥15.19 Million | CN¥408.75 Million | ▲ +194.8% |
| 2001 | -0.04x | CN¥-11.80 Million | CN¥300.99 Million | — |